tirzepatide and thyroid medication Nodules: Safety Evidence and Guidelines Tirzepitide: Next-Generation Weight Loss Solution

For sensitivity analysis, semaglutide or tirzepatide was not associated with any of 4 negative control outcomes, including medical encounters for congenital eye diseases diagnosis, medical encounters for any eye disease diagnosis, outpatient medical encounters, and all medical encounters (Figure 2)

Off-label uses include: Catatonia (a severe mental condition)

While joint pain relief is not an FDA-approved indication for GLP-1 medications, emerging clinical observations and patient reports have prompted investigation into potential musculoskeletal benefits

A medication that is safe for one person might be inappropriate for another based on their unique biology

This was also associated with significant improvement in the insulinogenic index in the high GLP-1 prediabetes group